Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.12
MDRX's Cash to Debt is ranked lower than
94% of the 1781 Companies
in the Global Software - Application industry.

( Industry Median: 20.60 vs. MDRX: 0.12 )
Ranked among companies with meaningful Cash to Debt only.
MDRX' s 10-Year Cash to Debt Range
Min: 0.06  Med: 0.87 Max: No Debt
Current: 0.12
Equity to Asset 0.51
MDRX's Equity to Asset is ranked lower than
65% of the 1579 Companies
in the Global Software - Application industry.

( Industry Median: 0.61 vs. MDRX: 0.51 )
Ranked among companies with meaningful Equity to Asset only.
MDRX' s 10-Year Equity to Asset Range
Min: 0.3  Med: 0.66 Max: 0.96
Current: 0.51
0.3
0.96
F-Score: 4
Z-Score: 1.58
M-Score: -2.85
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating margin (%) -1.33
MDRX's Operating margin (%) is ranked lower than
70% of the 1748 Companies
in the Global Software - Application industry.

( Industry Median: 5.11 vs. MDRX: -1.33 )
Ranked among companies with meaningful Operating margin (%) only.
MDRX' s 10-Year Operating margin (%) Range
Min: -666.68  Med: -0.96 Max: 14.84
Current: -1.33
-666.68
14.84
Net-margin (%) -3.01
MDRX's Net-margin (%) is ranked lower than
70% of the 1748 Companies
in the Global Software - Application industry.

( Industry Median: 3.20 vs. MDRX: -3.01 )
Ranked among companies with meaningful Net-margin (%) only.
MDRX' s 10-Year Net-margin (%) Range
Min: -590.73  Med: -2.45 Max: 8.92
Current: -3.01
-590.73
8.92
ROE (%) -3.16
MDRX's ROE (%) is ranked lower than
71% of the 1703 Companies
in the Global Software - Application industry.

( Industry Median: 6.27 vs. MDRX: -3.16 )
Ranked among companies with meaningful ROE (%) only.
MDRX' s 10-Year ROE (%) Range
Min: -215.05  Med: -0.08 Max: 10.96
Current: -3.16
-215.05
10.96
ROA (%) -1.60
MDRX's ROA (%) is ranked lower than
68% of the 1788 Companies
in the Global Software - Application industry.

( Industry Median: 3.29 vs. MDRX: -1.60 )
Ranked among companies with meaningful ROA (%) only.
MDRX' s 10-Year ROA (%) Range
Min: -198.14  Med: -0.05 Max: 6.14
Current: -1.6
-198.14
6.14
ROC (Joel Greenblatt) (%) -10.63
MDRX's ROC (Joel Greenblatt) (%) is ranked lower than
71% of the 1761 Companies
in the Global Software - Application industry.

( Industry Median: 24.35 vs. MDRX: -10.63 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
MDRX' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -2743.02  Med: -0.56 Max: 516.74
Current: -10.63
-2743.02
516.74
Revenue Growth (3Y)(%) 0.40
MDRX's Revenue Growth (3Y)(%) is ranked lower than
65% of the 1315 Companies
in the Global Software - Application industry.

( Industry Median: 5.30 vs. MDRX: 0.40 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
MDRX' s 10-Year Revenue Growth (3Y)(%) Range
Min: -28.7  Med: 10.80 Max: 24.4
Current: 0.4
-28.7
24.4
EBITDA Growth (3Y)(%) -18.40
MDRX's EBITDA Growth (3Y)(%) is ranked lower than
81% of the 1053 Companies
in the Global Software - Application industry.

( Industry Median: 6.80 vs. MDRX: -18.40 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
MDRX' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -67.6  Med: 7.60 Max: 105.3
Current: -18.4
-67.6
105.3
» MDRX's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2014

MDRX Guru Trades in Q3 2014

Jim Simons 243,465 sh (New)
Vanguard Health Care Fund 11,187,763 sh (+30.96%)
Chuck Royce 1,394,400 sh (+21.92%)
RS Investment Management 6,939,494 sh (+14.61%)
Michael Price 477,500 sh (unchged)
Third Avenue Management 1,930,793 sh (-4.69%)
Columbia Wanger 8,438,400 sh (-16.55%)
» More
Q4 2014

MDRX Guru Trades in Q4 2014

Jim Simons 1,273,265 sh (+422.98%)
RS Investment Management 8,435,749 sh (+21.56%)
Chuck Royce 1,469,500 sh (+5.39%)
Vanguard Health Care Fund 11,198,893 sh (+0.10%)
Michael Price 477,500 sh (unchged)
Columbia Wanger 4,110,094 sh (-51.29%)
Third Avenue Management 615,859 sh (-68.10%)
» More
Q1 2015

MDRX Guru Trades in Q1 2015

Steven Cohen 1,177,500 sh (New)
Paul Tudor Jones 46,066 sh (New)
Jim Simons 1,739,665 sh (+36.63%)
Chuck Royce 1,809,000 sh (+23.10%)
RS Investment Management 8,804,384 sh (+4.37%)
Michael Price 477,500 sh (unchged)
Third Avenue Management 615,859 sh (unchged)
Vanguard Health Care Fund 11,198,893 sh (unchged)
Columbia Wanger 3,872,094 sh (-5.79%)
» More
Q2 2015

MDRX Guru Trades in Q2 2015

First Eagle Investment 3,507,021 sh (New)
Vanguard Health Care Fund 11,198,893 sh (unchged)
First Eagle Investment 2,000 sh (unchged)
Third Avenue Management 615,859 sh (unchged)
Michael Price 477,500 sh (unchged)
Paul Tudor Jones Sold Out
Steven Cohen Sold Out
Chuck Royce 1,696,600 sh (-6.21%)
Jim Simons 1,449,865 sh (-16.66%)
Columbia Wanger 3,003,023 sh (-22.44%)
RS Investment Management 6,539,004 sh (-25.73%)
RS Investment Management 6,539,004 sh (-25.73%)
» More
» Details

Insider Trades

Latest Guru Trades with MDRX

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
Forward P/E 23.92
MDRX's Forward P/E is ranked lower than
63% of the 528 Companies
in the Global Software - Application industry.

( Industry Median: 19.16 vs. MDRX: 23.92 )
Ranked among companies with meaningful Forward P/E only.
N/A
P/B 1.89
MDRX's P/B is ranked higher than
63% of the 1572 Companies
in the Global Software - Application industry.

( Industry Median: 2.63 vs. MDRX: 1.89 )
Ranked among companies with meaningful P/B only.
MDRX' s 10-Year P/B Range
Min: 0.79  Med: 2.54 Max: 8.14
Current: 1.89
0.79
8.14
P/S 1.82
MDRX's P/S is ranked higher than
53% of the 1715 Companies
in the Global Software - Application industry.

( Industry Median: 2.00 vs. MDRX: 1.82 )
Ranked among companies with meaningful P/S only.
MDRX' s 10-Year P/S Range
Min: 0.91  Med: 3.44 Max: 7.12
Current: 1.82
0.91
7.12
PFCF 27.06
MDRX's PFCF is ranked lower than
56% of the 815 Companies
in the Global Software - Application industry.

( Industry Median: 24.41 vs. MDRX: 27.06 )
Ranked among companies with meaningful PFCF only.
MDRX' s 10-Year PFCF Range
Min: 10.36  Med: 50.99 Max: 2780
Current: 27.06
10.36
2780
POCF 16.05
MDRX's POCF is ranked higher than
55% of the 1017 Companies
in the Global Software - Application industry.

( Industry Median: 17.74 vs. MDRX: 16.05 )
Ranked among companies with meaningful POCF only.
MDRX' s 10-Year POCF Range
Min: 5.8  Med: 27.99 Max: 84.24
Current: 16.05
5.8
84.24
Current Ratio 1.04
MDRX's Current Ratio is ranked lower than
84% of the 1625 Companies
in the Global Software - Application industry.

( Industry Median: 2.07 vs. MDRX: 1.04 )
Ranked among companies with meaningful Current Ratio only.
MDRX' s 10-Year Current Ratio Range
Min: 0.98  Med: 1.80 Max: 23.84
Current: 1.04
0.98
23.84
Quick Ratio 1.04
MDRX's Quick Ratio is ranked lower than
80% of the 1625 Companies
in the Global Software - Application industry.

( Industry Median: 1.92 vs. MDRX: 1.04 )
Ranked among companies with meaningful Quick Ratio only.
MDRX' s 10-Year Quick Ratio Range
Min: 0.73  Med: 1.75 Max: 23.25
Current: 1.04
0.73
23.25
Days Sales Outstanding 86.02
MDRX's Days Sales Outstanding is ranked lower than
65% of the 1511 Companies
in the Global Software - Application industry.

( Industry Median: 69.32 vs. MDRX: 86.02 )
Ranked among companies with meaningful Days Sales Outstanding only.
MDRX' s 10-Year Days Sales Outstanding Range
Min: 71.08  Med: 88.19 Max: 146.31
Current: 86.02
71.08
146.31

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 1.33
MDRX's Price/Projected FCF is ranked higher than
62% of the 823 Companies
in the Global Software - Application industry.

( Industry Median: 1.66 vs. MDRX: 1.33 )
Ranked among companies with meaningful Price/Projected FCF only.
MDRX' s 10-Year Price/Projected FCF Range
Min: 0.82  Med: 1.88 Max: 6.76
Current: 1.33
0.82
6.76
Price/Median PS Value 0.52
MDRX's Price/Median PS Value is ranked higher than
91% of the 1520 Companies
in the Global Software - Application industry.

( Industry Median: 1.11 vs. MDRX: 0.52 )
Ranked among companies with meaningful Price/Median PS Value only.
MDRX' s 10-Year Price/Median PS Value Range
Min: 0.34  Med: 0.95 Max: 9.45
Current: 0.52
0.34
9.45
Earnings Yield (Greenblatt) (%) -0.50
MDRX's Earnings Yield (Greenblatt) (%) is ranked lower than
68% of the 1711 Companies
in the Global Software - Application industry.

( Industry Median: 2.80 vs. MDRX: -0.50 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
MDRX' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 0.1  Med: 1.90 Max: 5.9
Current: -0.5
0.1
5.9
Forward Rate of Return (Yacktman) (%) -7.48
MDRX's Forward Rate of Return (Yacktman) (%) is ranked lower than
82% of the 694 Companies
in the Global Software - Application industry.

( Industry Median: 10.48 vs. MDRX: -7.48 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
MDRX' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: -10.9  Med: 1.60 Max: 69.6
Current: -7.48
-10.9
69.6

Analyst Estimate

Dec15 Dec16 Dec17
Revenue(Mil) 1,408 1,489 1,558
EPS($) 0.44 0.58 0.64
EPS without NRI($) 0.44 0.58 0.64

Business Description

Industry: Application Software » Software - Application
Compare:CERN, CTRX, ATHN, AH, QSII » details
Traded in other countries:AL21.Germany,
Allscripts Healthcare Solutions Inc was founded in 1986. The Company provides clinical, financial, connectivity and information solutions and related professional services that empower hospitals, physicians and post-acute organizations to deliver world-class outcomes. The Company operates in three reportable segments: Clinical and Financial Solutions, Population Health, and Managed Services. The Clinical and Financial Solutions segment includes its Acute, TouchWorks, Professional Practices, Payer and Life Sciences, and International strategic business units. These solutions primarily include EHR-related software, financial and practice management software, related installation and training services, and electronic claims administration services. The Population Health segment includes its Performance and Care Logistics and Population Health strategic business units. The Managed Services segment includes its Outsourcing and Remote Hosting strategic business units. The Company delivers solutions that provide physicians and other healthcare professionals with the data, information, insights, and connectivity required to transform health care by improving the quality and efficiency of patient care and to navigate the transition from fee-for-service to value-based care. Allscripts Sunrise is its integrated complete Electronic Health Record ("EHR") solution for hospitals, health systems, and physicians, marrying powerful clinical capabilities with next-generation revenue care and administrative solutions. Its performance and care logistics solutions include analytics solutions that provide health system professionals with the insight they need to manage financial performance across a complex organization. It also provides solutions for home care, hospice, skilled nursing, and other post-acute organizations, including a fully-integrated EHR and financial management solution. For physician practices of every size and specialty, its solutions include integrated EHR and practice management functionality, which is available either via traditional on-premise delivery or as a hosted service, as well as revenue cycle management services, clearinghouse services, and stand-alone electronic prescribing. It also provides solutions for home care, hospice, skilled nursing, and other post-acute organizations. These range from a fully integrated EHR and financial management solution to referral management. The Company offers several types of solutions that are tailored towards different segments of the market in which it operates and which support healthcare delivery in every care setting. It also offers various add-ons to increase the functionality of its product offerings. The Company sells directly to its clients through its direct sales force. Its competitors in the physician healthcare information systems and services market include, but are not limited to, ADP, Advanced Data Systems Corporation, Aprima Medical Software, athenahealth Inc., Cerner
» More Articles for MDRX

Headlines

Articles On GuruFocus.com
First Eagle Investment Buys 19 Stakes in Second Quarter Aug 17 2015 
dale Aug 05 2015 
dale Aug 05 2015 
dale Aug 05 2015 
Columbia Management's Top 5 New Buys Amid Buoyant Outlook Aug 12 2013 
Weekly CEO Buys Highlight: AKAM, DRC, MDRX, MTG, CDXS Mar 17 2013 
American Insider Trades: March 8-15 Mar 15 2013 
The Barclays Triggers More Insider Buying Mar 13 2013 
Allscripts-Misys Reports 5 Insider Buys the Day Before Barclays Conference Mar 13 2013 
Edward Owens’ 3 Biggest Stock Increases Feb 05 2013 

More From Other Websites
Cookeville Medical Center Selects Allscripts for Chronic Care Management (CCM) Program Aug 25 2015
Cookeville Medical Center Selects Allscripts for Chronic Care Management (CCM) Program Aug 25 2015
Allscripts-Misys Healthcare upgraded by Argus Aug 24 2015
Allscripts EHR Solutions' Consistent Success: Key to Growth Aug 21 2015
ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws;... Aug 20 2015
Allscripts Allies with CoverMyMeds to Advance eAuth Software Aug 20 2015
Allscripts Partners With CoverMyMeds to Help Patients Fill Prescriptions Faster Aug 20 2015
Allscripts Partners With CoverMyMeds to Help Patients Fill Prescriptions Faster Aug 19 2015
Allscripts Ambulatory/ Alternate Site Solutions Ranked No. 1 by Black Book(TM) Rankings Aug 19 2015
First Eagle Investment Buys 19 Stakes in Second Quarter Aug 17 2015
ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. Financials Aug 13 2015
Henry Schein, Inc. Earnings Q2*, 2015 Aug 11 2015
Allscripts Announces Upcoming Investor Events Aug 11 2015
Allscripts Announces Upcoming Investor Events Aug 11 2015
10-Q for Allscripts Healthcare Solutions, Inc. Aug 07 2015
Allscripts (MDRX) Stock Price Target Raised at Leerink Aug 07 2015
Has Allscripts' Q2 Earnings Results Disappointed Investors? - Analyst Blog Aug 06 2015
ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. Files SEC form 10-Q, Quarterly Report Aug 05 2015
Edited Transcript of MDRX earnings conference call or presentation 4-Aug-15 8:30pm GMT Aug 04 2015
After-hours buzz: Etsy, Zillow, Disney & more Aug 04 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK